Abstract
Stereotactic body radiotherapy with and without sorafenib for the treatment of advanced hepatocellular carcinoma: A comparison of therapeutic outcomes in follow-up analyses
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have